Search

Volunteers are highly valued members of the Retina UK team and essential to our ability to achieve our vision of a world where all those affected by inherited retinal conditions are able to live a fulfilling life.

A recording of the 45th Retina UK Annual Conference on 9 July 2022. The Conference was held at the Macdonald Burlington Hotel in Birmingham and also online.

• Conference
• Audio
• Video

Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.

• News

We talk to BBC reporter Ramadan Younes and Professor Robert Maclaren following the BBC documentary Blind Faith

• Podcast
• Audio

Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.

• e-Newsletter
• Audio
• Written

The latest podcast from Retina UK.

• Podcast
• Audio

Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.

• News
• Leber congenital amaurosis (LCA)

Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP

• News
• Retinitis pigmentosa

Mirugen – Unlocking the Power of Retina Regeneration

• News
• Retinitis pigmentosa
• Stargardt disease

The latest research news from Retina UK.

• News
• Stargardt disease